Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
Net Income ScalingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$202.26M
↑ 297% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
$-102.65M
Historical baseline
PeriodValueYoY Change
TTM$202.26M+12501.3%
2025$-1.63M+99.7%
2024$-599.49M-192.0%
2023$-205.28M-16.6%
2022$-176.06M-25.0%
2021$-140.85M-66.6%
2020$-84.55M-224.4%
2019$67.97M+224.8%
2018$-54.45M-58.4%
2017$-34.38M-